Company / PP&E per Share
Amgen PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$14.74
FY2025
5-year range
$8.96 / $14.74
FY2021-FY2025
Trend
+20.6%
vs FY2024
Sector context
#6 of 193
Health Care
What the data says
Among 193 Health Care companies, Amgen is in the top 3% for pp&e per share. PP&E per Share has increased for 9 consecutive years, from $6.58 in FY2016 to $14.74 in FY2025.
Based on SEC 10-K filings.
14.74 in FY2025 with a 5-year CAGR of +12.3%. Top quartile in the Health Care sector.
Improved from $11.13 to $14.74 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- +12.3%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 193This company $14.74 Sector average $18.71
▼
-21.2% below sector average
Key checks
Key Insights
- Amgen's pp&e per share has grown for 9 consecutive years.
- In FY2025, pp&e per share increased 20.6% year-over-year.
- Ranks #6 out of 193 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.74 | +20.6% |
| FY2024 | $12.22 | +9.8% |
| FY2023 | $11.13 | +14.5% |
| FY2022 | $9.72 | +8.4% |
| FY2021 | $8.96 | +8.4% |
| FY2020 | $8.27 | +5.6% |
| FY2019 | $7.83 | +14.0% |
| FY2018 | $6.87 | +1.6% |
| FY2017 | $6.76 | +2.7% |
| FY2016 | $6.58 | +2.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026